JLE

European Journal of Dermatology

MENU

Erythema multiforme-like rash upon anti-melanoma therapy with BRAF and MEK inhibitors Volume 29, issue 1, January-February 2019

Figures


  • Figure 1
Authors
Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany

Cutaneous side effects are very common among the increasing number of new anti-cancer therapeutics. Novel melanoma therapeutics, in particular, exhibit a broad spectrum of adverse events that affect the skin with varying clinical presentation. As part of the Resident's Corner section, starting with this edition, a series of cases illustrating cutaneous side effects due to novel cancer therapeutics will be presented.Our first case refers to a 53-year-old woman suffering from advanced cutaneous, BRAF-mutated [...]